Evidence map›Paper›PMID 42239329›Full record

ArticlebioRxiv : the preprint server for biology2026

Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model.

YoungDoo Kim, Bhupesh Vaidya, Jiyoen Kim, Sara Bitar, Femil Joseph Shajan, Ajay Kumar Verma, Hari Krishna Yalamanchili, Shubham Singh, Huda Y Zoghbi

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

YoungDoo KimDepartment of Molecular and Human Genetics, Baylor College of Medicine (BCM).ORCID 0000-0003-3231-7371
Bhupesh VaidyaDepartment of Molecular and Human Genetics, Baylor College of Medicine (BCM).ORCID 0000-0003-2003-6695
Jiyoen KimDepartment of Molecular and Human Genetics, Baylor College of Medicine (BCM).ORCID 0000-0003-1813-8270
Sara BitarDepartment of Molecular and Human Genetics, Baylor College of Medicine (BCM).ORCID 0000-0002-9369-0500
Femil Joseph ShajanJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital.
Ajay Kumar VermaDepartment of Pediatrics, BCM.ORCID 0000-0002-4163-0100
Hari Krishna YalamanchiliDepartment of Pediatrics, BCM.ORCID 0000-0001-9892-3054
Shubham SinghJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital.ORCID 0000-0002-2428-7718
Huda Y ZoghbiDepartment of Molecular and Human Genetics, Baylor College of Medicine (BCM).ORCID 0000-0002-0700-3349

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, SAMACO, RODNEY C · 2014 to 2019
$7.8M
NICHD NIH HHS U54 HD083092
6 · The paper itself

Abstract

Astrocytes are key regulators of lipid metabolism, and dysregulated astrocytic lipid processing is implicated in Parkinson's disease (PD) pathogenesis. Our prior genome-wide screens identified ACSBG1, an astrocyte-enriched acyl-CoA synthetase, as a candidate regulator of α-synuclein (α-Syn) levels. However, how ACSBG1 links lipid reprogramming to inflammatory astrocyte activation and α-Syn pathology remains unknown. We compared the transcriptomic, cytokine, and lipid secretomes of TNF-α and IL-1α stimulated primary astrocytes from wild-type (WT) and

Indexed as

ACSBG1astrocytesinflammationlipidsParkinson’s diseaseα-Syn

Identifiers

PMID42239329
PMCPMC13228550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.